STAAR Surgical (STAA) Enters Strategic Agreement with Turkey-Based World Eye Hospital Group
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
STAAR Surgical Announces Strategic Cooperation Agreement With World Eye Hospital Group
September 7, 2016 7:00 AM EDTMONROVIA, Calif., Sept. 7, 2016 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and World Eye Hospital Group headquartered in Istanbul, Turkey today announced that they have entered into an agreement to provide STAAR's EVO Visian ICL® intraocular lenses as a primary and premium option for refractive eye treatment.Â
"World Eye Hospital Group (Dünya Göz) is pleased to enter into this Strategic Cooperation Agreement with STAAR Surgical. As the largest refractive eye surgery provider... More